Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | CRL | IQV |
|---|---|---|
| Price | $288.83 | $262.87 |
| Change today | ▼ 2.10% | ▼ 2.22% |
| Market cap | $13.79B | $43.27B |
| Return, 3 months | +26.1% | – |
| Return, year to date | +44.8% | – |
| Return, 1 year | +69.4% | – |
| P/E (TTM) | -60.2 | 32.7 |
| P/B | 4.9 | 7.0 |
| P/E percentile vs own 5y | 19th | 55th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -0.9% | +8.7% |
| Net profit growth (YoY) | -662.1% | -3.0% |
| Gross margin | 32.7% | 33.0% |
| Operating margin | 11.7% | 13.9% |
| Net margin | -6.0% | 8.1% |
| Return on equity | -7.7% | 23.0% |
| Analyst target vs. price | +10.7% | +9.1% |
| Analyst buy share | 93% | 93% |
| RSI (14) | 61 | – |
| 30-day volatility | 32.1% | – |
| Max drawdown, 1 year | -33.9% | – |
| Trend read | Strong uptrend | – |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
